{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:30:53Z","timestamp":1790951453888,"version":"4.1.0"},"reference-count":44,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T00:00:00Z","timestamp":1657929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council (NHMRC) Partnership project","doi-asserted-by":"publisher","award":["1103165"],"award-info":[{"award-number":["1103165"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council (NHMRC) Partnership project","doi-asserted-by":"publisher","award":["R01DA1104470"],"award-info":[{"award-number":["R01DA1104470"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council (NHMRC) Partnership project","doi-asserted-by":"publisher","award":["2008276"],"award-info":[{"award-number":["2008276"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council (NHMRC) Partnership project","doi-asserted-by":"publisher","award":["1176131"],"award-info":[{"award-number":["1176131"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Investigator-Initiated Studies Program of Merck, Sharp and Dohme Corporation","award":["1103165"],"award-info":[{"award-number":["1103165"]}]},{"name":"Investigator-Initiated Studies Program of Merck, Sharp and Dohme Corporation","award":["R01DA1104470"],"award-info":[{"award-number":["R01DA1104470"]}]},{"name":"Investigator-Initiated Studies Program of Merck, Sharp and Dohme Corporation","award":["2008276"],"award-info":[{"award-number":["2008276"]}]},{"name":"Investigator-Initiated Studies Program of Merck, Sharp and Dohme Corporation","award":["1176131"],"award-info":[{"award-number":["1176131"]}]},{"name":"Australian Government Department of Health and Ageing","award":["1103165"],"award-info":[{"award-number":["1103165"]}]},{"name":"Australian Government Department of Health and Ageing","award":["R01DA1104470"],"award-info":[{"award-number":["R01DA1104470"]}]},{"name":"Australian Government Department of Health and Ageing","award":["2008276"],"award-info":[{"award-number":["2008276"]}]},{"name":"Australian Government Department of Health and Ageing","award":["1176131"],"award-info":[{"award-number":["1176131"]}]},{"name":"US National Institute of Health (NIH)","award":["1103165"],"award-info":[{"award-number":["1103165"]}]},{"name":"US National Institute of Health (NIH)","award":["R01DA1104470"],"award-info":[{"award-number":["R01DA1104470"]}]},{"name":"US National Institute of Health (NIH)","award":["2008276"],"award-info":[{"award-number":["2008276"]}]},{"name":"US National Institute of Health (NIH)","award":["1176131"],"award-info":[{"award-number":["1176131"]}]},{"name":"National Institute on Drug Abuse (NIDA)","award":["1103165"],"award-info":[{"award-number":["1103165"]}]},{"name":"National Institute on Drug Abuse (NIDA)","award":["R01DA1104470"],"award-info":[{"award-number":["R01DA1104470"]}]},{"name":"National Institute on Drug Abuse (NIDA)","award":["2008276"],"award-info":[{"award-number":["2008276"]}]},{"name":"National Institute on Drug Abuse (NIDA)","award":["1176131"],"award-info":[{"award-number":["1176131"]}]},{"name":"National Health and Medical Research Council (NHMRC) Investigator","award":["1103165"],"award-info":[{"award-number":["1103165"]}]},{"name":"National Health and Medical Research Council (NHMRC) Investigator","award":["R01DA1104470"],"award-info":[{"award-number":["R01DA1104470"]}]},{"name":"National Health and Medical Research Council (NHMRC) Investigator","award":["2008276"],"award-info":[{"award-number":["2008276"]}]},{"name":"National Health and Medical Research Council (NHMRC) Investigator","award":["1176131"],"award-info":[{"award-number":["1176131"]}]},{"name":"NHMRC Investigator","award":["1103165"],"award-info":[{"award-number":["1103165"]}]},{"name":"NHMRC Investigator","award":["R01DA1104470"],"award-info":[{"award-number":["R01DA1104470"]}]},{"name":"NHMRC Investigator","award":["2008276"],"award-info":[{"award-number":["2008276"]}]},{"name":"NHMRC Investigator","award":["1176131"],"award-info":[{"award-number":["1176131"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>This study evaluated HCV treatment initiation among people who inject drugs (PWID) following an intervention of campaign days involving peer connection, point-of-care HCV RNA testing, and linkage to nursing support. ETHOS Engage is an observational cohort study of PWID attending 25 drug treatment clinics and needle and syringe programs in Australia (May 2018\u2013September 2019). Point-of-care results were provided to the nurse, facilitating confirmatory testing and treatment. The study aimed to evaluate treatment uptake and factors associated with treatment at 24 months post-enrolment. There were 317 people with current HCV infection and eligible for treatment (median age 43, 65% male, 15% homeless, 69% receiving opioid agonist treatment, 70% injected in last month). Overall, 15% (47\/317), 27% (85\/317), 38% (120\/317), and 49% (155\/317) of people with current HCV infection had initiated treatment at 3-, 6-, 12-, and 24-months following testing, respectively. Homelessness (adjusted hazard ratio (aHR): 0.40; 95% confidence interval: 0.23, 0.71) and incarceration in the past 12 months (vs. never, aHR:0.46; 0.28, 0.76) were associated with decreased treatment initiation in the 24 months post-enrolment. This testing campaign intervention facilitated HCV treatment uptake among PWID. Further interventions are needed to achieve HCV elimination among people experiencing homelessness or incarceration.<\/jats:p>","DOI":"10.3390\/v14071555","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T01:53:22Z","timestamp":1658109202000},"page":"1555","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9082-9714","authenticated-orcid":false,"given":"Anna","family":"Conway","sequence":"first","affiliation":[{"name":"The Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia"},{"name":"Centre for Social Research in Health, UNSW Sydney, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Valerio","sequence":"additional","affiliation":[{"name":"The Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Alavi","sequence":"additional","affiliation":[{"name":"The Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Silk","sequence":"additional","affiliation":[{"name":"The Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Treloar","sequence":"additional","affiliation":[{"name":"Centre for Social Research in Health, UNSW Sydney, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2212-2028","authenticated-orcid":false,"given":"Behzad","family":"Hajarizadeh","sequence":"additional","affiliation":[{"name":"The Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison D.","family":"Marshall","sequence":"additional","affiliation":[{"name":"The Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia"},{"name":"Centre for Social Research in Health, UNSW Sydney, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Martinello","sequence":"additional","affiliation":[{"name":"The Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Milat","sequence":"additional","affiliation":[{"name":"Centre for Epidemiology and Evidence, NSW Health, Sydney, NSW 2065, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Dunlop","sequence":"additional","affiliation":[{"name":"Hepatitis NSW, Surry Hills, NSW 2010, Australia"},{"name":"Drug and Alcohol Clinical Services, Hunter New England Local Health District, Newcastle, NSW 2300, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Murray","sequence":"additional","affiliation":[{"name":"Population Health Strategy & Performance, NSW Health, Sydney, NSW 2065, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Prain","sequence":"additional","affiliation":[{"name":"Population Health Strategy & Performance, NSW Health, Sydney, NSW 2065, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Henderson","sequence":"additional","affiliation":[{"name":"NSW Users and AIDS Association, Surry Hills, NSW 2010, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janaki","family":"Amin","sequence":"additional","affiliation":[{"name":"Department of Health Systems and Populations, Macquarie University, Sydney, NSW 2109, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Read","sequence":"additional","affiliation":[{"name":"Kirketon Road Centre, Sydney, NSW 2010, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pip","family":"Marks","sequence":"additional","affiliation":[{"name":"The Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Degenhardt","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Hayllar","sequence":"additional","affiliation":[{"name":"Alcohol and Drug Service, Metro North Mental Health, Metro North Hospital and Health Service, Brisbane, QLD 4029, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Reid","sequence":"additional","affiliation":[{"name":"Drug and Alcohol Service, Illawarra Shoalhaven Local Health District, Wollongong, NSW 2500, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Gorton","sequence":"additional","affiliation":[{"name":"Cairns Sexual Health Service, Cairns, QLD 4870, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thao","family":"Lam","sequence":"additional","affiliation":[{"name":"Drug Health, Western Sydney Local Health District, Sydney, NSW 2145, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Christmass","sequence":"additional","affiliation":[{"name":"Next Step Community Alcohol and Drug Service, Perth, WA 6004, Australia"},{"name":"National Drug Research Institute, Curtin University, Perth, WA 6102, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Wade","sequence":"additional","affiliation":[{"name":"Mid North Coast Liver Clinic, Mid North Coast Local Health District, Coffs Harbour, NSW 2450, Australia"},{"name":"Drug and Alcohol Services, Mid North Coast Local Health District, Coffs Harbour, NSW 2450, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1776-3974","authenticated-orcid":false,"given":"Mark","family":"Montebello","sequence":"additional","affiliation":[{"name":"North Sydney Local Health District, Sydney, NSW 2077, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Dore","sequence":"additional","affiliation":[{"name":"The Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1833-2017","authenticated-orcid":false,"given":"Jason","family":"Grebely","sequence":"additional","affiliation":[{"name":"The Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,16]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2016). Global Health Sector Strategy on Viral Hepatitis 2016-2021: Towards Ending Viral Hepatitis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/add.14393","article-title":"Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs","volume":"114","author":"Grebely","year":"2019","journal-title":"Addiction"},{"key":"ref_3","unstructured":"UNAIDS-Joint United Nations Programme on HIV\/AIDS (2019). Health, Rights and Drugs-Harm Reduction, Decriminalization and Zero Discrimination for People Who Use Drugs, UNAIDS."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/09687630500481150","article-title":"Hepatitis C and injecting-related discrimination in New South Wales, Australia","volume":"13","author":"Hopwood","year":"2006","journal-title":"Drugs Educ. Prev. Policy"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7517-10-7","article-title":"Hepatitis C treatment access and uptake for people who inject drugs: A review mapping the role of social factors","volume":"10","author":"Harris","year":"2013","journal-title":"Harm Reduct. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/jvh.12852","article-title":"Uptake of direct-acting antiviral treatment for chronic hepatitis C in Australia","volume":"25","author":"Hajarizadeh","year":"2017","journal-title":"J. Viral Hepat."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1093\/cid\/ciaa571","article-title":"Progress Towards Elimination of Hepatitis C Infection Among People Who Inject Drugs in Australia: The ETHOS Engage Study","volume":"73","author":"Valerio","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"103706","DOI":"10.1016\/j.drugpo.2022.103706","article-title":"Declining Prevalence of Current HCV Infection and Increased Treatment Uptake Among People Who Inject Drugs: The ETHOS Engage Study","volume":"105","author":"Valerio","year":"2022","journal-title":"Int. J. Drug Policy"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugpo.2017.07.002","article-title":"Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review","volume":"47","author":"Bajis","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1016\/S2214-109X(20)30505-2","article-title":"Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: A global systematic review and meta-analysis","volume":"9","author":"Oru","year":"2021","journal-title":"Lancet Glob. Health"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/jvh.13233","article-title":"Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study","volume":"27","author":"Bajis","year":"2020","journal-title":"J. Viral Hepat."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-021-06555-0","article-title":"Increasing integrated testing in community settings through interventions for change, including the Spring European Testing Week","volume":"21","author":"Gasbarrini","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S2468-1253(21)00471-4","article-title":"Interventions to enhance testing and linkage to treatment for hepatitis C infection: A systematic review and meta-analysis","volume":"7","author":"Cunningham","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"EASL (2020). EASL recommendations on treatment of hepatitis C: Final update of the series. J. Hepatol., 73, 1170\u20131218.","DOI":"10.1016\/j.jhep.2020.08.018"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jhep.2020.08.038","article-title":"High hepatitis C treatment uptake among people with recent drug dependence in New South Wales, Australia","volume":"74","author":"Valerio","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_16","first-page":"1842","article-title":"The AUDIT Alcohol Consumption Questions","volume":"22","author":"Bradley","year":"1998","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Mauss, S., Pol, S., Buti, M., Duffell, E., Gore, C., Lazarus, J.V., Logtenberg-van der Grient, H.L., Lundgren, J., Mozalevskis, A., and Raben, D. (2017). Late presentation of chronic viral hepatitis for medical care: A consensus definition. BMC Med., 15.","DOI":"10.1186\/s12916-017-0856-y"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Yousafzai, M.T., Alavi, M., Valerio, H., Hajarizadeh, B., Grebely, J., and Dore, G.J. (2022). Time to hepatitis C RNA testing and treatment in the era of direct-acting antiviral therapy among people with hepatitis C in New South Wales, Australia. Viruses., 14.","DOI":"10.3390\/v14071496"},{"key":"ref_19","unstructured":"Grebely, J., Gilliver, R., Mcnaughton, T., Henderson, C., Hadlow, B., Molloy, K., Tillakeratne, S., Pepolim, L., Harrod, M.E., and Dore, G.J. (2021, January 13\u201315). Point-of-care HCV RNA testing, linkage to nursing care, and peer-supported engagement and delivery to enhance HCV treatment among people with recent injecting drug use at a community-led needle and syringe program: The TEMPO pilot study. Proceedings of the International Conference on Hepatitis Care in Substance Users, Virtual conference."},{"key":"ref_20","unstructured":"Macisaac, M.B., Whitton, B., Anderson, J., Hornung, M., Elmore, K., Pemberton, D., Penn, M., Hellard, M., Stoove, M., and Wilson, D. (2021, January 13\u201315). Rapid point of care HCV testing allows high throughout HCV screening and rapid treatment uptake among PWID attending a medically supervised injecting room. Proceedings of the International Conference on Hepatitis Care in Substance Users, Virtual conference."},{"key":"ref_21","unstructured":"O\u2019Loan, J., Young, M., Mooney, M., and O\u2019Flynn, M. (2021, January 13\u201315). Same day delivery! HCV point of care testing in South East Queensland marginalised communities simplifies diagnosis and ensures rapid access to treatment. Proceedings of the International Conference on Hepatitis Care in Substance Users, Virtual conference."},{"key":"ref_22","unstructured":"Ralton, L., McCartney, E.M., Ferguson, C., Dawe, J., Richmond, J., Tse, E., Wigg, A., Cock, V., Rees, T., and Sha, D. (2021, January 13\u201315). Prompt-point of care testing for hepatitis C in the priority settings of mental health, prisons and drug & alcohol facilities. Proceedings of the International Conference on Hepatitis Care in Substance Users, Virtual conference."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugpo.2018.08.011","article-title":"Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia","volume":"61","author":"Bajis","year":"2018","journal-title":"Int. J. Drug Policy"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/jvh.13112","article-title":"Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study","volume":"26","author":"Bajis","year":"2019","journal-title":"J. Viral Hepat."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0207226","article-title":"Beyond interferon side effects: What residual barriers exist to DAA hepatitis C treatment for people who inject drugs?","volume":"13","author":"Madden","year":"2018","journal-title":"PLoS ONE"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/hex.13400","article-title":"Barriers and facilitators to hepatitis C screening and treatment for people with lived experience of homelessness: A mixed-methods systematic review","volume":"25","author":"Paisi","year":"2021","journal-title":"Health Expect."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1016\/S2468-2667(21)00258-9","article-title":"The contribution of unstable housing to HIV and hepatitis C virus transmission among people who inject drugs globally, regionally, and at country level: A modelling study","volume":"7","author":"Stone","year":"2022","journal-title":"Lancet Public Health"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-020-09224-0","article-title":"Housing as a social determinant of health and wellbeing: Developing an empirically-informed realist theoretical framework","volume":"20","author":"Rolfe","year":"2020","journal-title":"BMC Public Health"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/liv.15095","article-title":"Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point-of-care","volume":"42","author":"Valencia","year":"2021","journal-title":"Liver Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"103424","DOI":"10.1016\/j.drugpo.2021.103424","article-title":"Detection of active hepatitis C in a single visit and linkage to care among marginalized people using a mobile unit in Madrid, Spain","volume":"96","author":"Ryan","year":"2021","journal-title":"Int. J. Drug Policy"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"109438","DOI":"10.1016\/j.drugalcdep.2022.109438","article-title":"Willingness of people who inject drugs to participate in a randomised controlled trial involving financial incentives to initiate hepatitis C treatment","volume":"235","author":"Marshall","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/cid\/ciab526","article-title":"Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage Study","volume":"73","author":"Valerio","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S2468-1253(21)00077-7","article-title":"Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): A prospective cohort study","volume":"6","author":"Hajarizadeh","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"103261","DOI":"10.1016\/j.drugpo.2021.103261","article-title":"Structural competency in the post-prison period for people who inject drugs: A qualitative case study","volume":"95","author":"Treloar","year":"2021","journal-title":"Int. J. Drug Policy"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-019-4344-1","article-title":"Linkage to hepatitis C care after incar-ceration in jail: A prospective, single arm clinical trial","volume":"19","author":"Akiyama","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S1473-3099(20)30730-1","article-title":"Decarceration and community re-entry in the COVID-19 era","volume":"21","author":"Ghandnoosh","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/hep.30171","article-title":"Has Access to Hepatitis C Virus Therapy Changed for Patients With Mental Health or Substance Use Disorders in the Direct-Acting-Antiviral Period?","volume":"69","author":"Jain","year":"2019","journal-title":"Hepatology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.socscimed.2013.01.031","article-title":"Taming systems to create enabling environments for HCV treatment: Negotiating trust in the drug and alcohol setting","volume":"83","author":"Harris","year":"2013","journal-title":"Soc. Sci. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.drugpo.2017.08.004","article-title":"Beyond the willing & the waiting\u2014The role of peer-based approaches in hepatitis C diagnosis & treatment","volume":"50","author":"Henderson","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.drugpo.2015.01.005","article-title":"Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, Australia","volume":"26","author":"Treloar","year":"2015","journal-title":"Int. J. Drug Policy"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"107705","DOI":"10.1016\/j.drugalcdep.2019.107705","article-title":"Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists\u2014The practitioner experience","volume":"206","author":"Marshall","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"ref_42","unstructured":"O\u2019Flynn, M., Young, M., White, S., Grimstrup, D., Mooney, M., and O\u2019Loan, J. (2021, January 13\u201315). HCV Blitzing in Corrections with Just a Fingerstick. Proceedings of the International Network on Health and Hepatitis in Substance Users Conference, Virtual conference."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1016\/S2352-3018(17)30073-5","article-title":"HIV and the criminalisation of drug use among people who inject drugs: A systematic review","volume":"4","author":"DeBeck","year":"2017","journal-title":"Lancet HIV"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(17)31869-X","article-title":"Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: A systematic review and meta-analysis","volume":"391","author":"Aldridge","year":"2018","journal-title":"Lancet"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/7\/1555\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:51:55Z","timestamp":1760140315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/7\/1555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,16]]},"references-count":44,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["v14071555"],"URL":"https:\/\/doi.org\/10.3390\/v14071555","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,16]]}}}